Compare Align Technology, Inc. (ALGN) vs iShares MSCI China ETF (MCHI) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Align Technology, Inc. vs iShares MSCI China ETF — how do they compare? Align Technology, Inc. trades at $179.45 (market cap $12.86B), while iShares MSCI China ETF trades at $52.99. The key difference: Align Technology, Inc. is trading nearer its 52-week high, iShares MSCI China ETF nearer its low. Which is the better fit depends on your goals.
| ALGN | MCHI | |
|---|---|---|
Market Cap | $12.86B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $207.19 | $66.99 |
52-Week Low | $124.88 | $50.48 |
Enterprise Value | $11.92B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
MCHI trades at $53.13, down 0.11% on the day, with technical indicators showing a mixed but overall bullish bias. The stock exhibits neutral oscillators but bullish moving averages, while key support and resistance cluster around $53. Recent news highlights China's AI and manufacturing rebound as potential catalysts, though financial ratios are currently unavailable for fundamental assessment.
Outlook remains cautiously optimistic given technical strength and sector tailwinds, but risks include U.S.-China tech tensions and value trap concerns. Investment appeal hinges on China's economic stabilization and AI sector growth, balanced against geopolitical and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About iShares MSCI China ETF
MCHI is an ETF that seeks to track the investment results of the MSCI China Index. It provides broad exposure to the Chinese equity market, primarily focusing on large and mid-cap companies listed in Hong Kong and Shanghai. MCHI serves as a core holding for investors looking to gain diversified exposure to the performance and growth potential of the companies within the People's Republic of China.
Read more on MCHI →
